Stockscreener 앱 받기
7.19
0.14%
-0.010
시간 외 거래:
7.38
0.19
+2.64%
전일 마감가:
$7.20
열려 있는:
$7.21
하루 거래량:
85,320
Relative Volume:
0.40
시가총액:
$674.12M
수익:
$106.66M
순이익/손실:
$15.16M
주가수익비율:
76.90
EPS:
0.0935
순현금흐름:
$6.37M
1주 성능:
+8.12%
1개월 성능:
-11.45%
6개월 성능:
-40.58%
1년 성능:
-29.02%
1일 변동 폭
$7.035
$7.37
1주일 범위
$6.70
$7.47
52주 변동 폭
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
명칭
Gyre Therapeutics Inc
전화
(619) 949-3681
주소
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
GYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.19 | 636.41M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-11 | 개시 | Noble Capital Markets | Outperform |
| 2021-04-29 | 재개 | Stephens | Overweight |
| 2021-02-10 | 개시 | Piper Sandler | Overweight |
| 2020-05-21 | 개시 | Raymond James | Outperform |
| 2019-01-04 | 개시 | Oppenheimer | Outperform |
| 2018-02-12 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 재확인 | Chardan Capital Markets | Buy |
| 2017-12-08 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 개시 | Chardan Capital Markets | Buy |
| 2017-06-06 | 개시 | Ladenburg Thalmann | Buy |
| 2016-06-30 | 개시 | Rodman & Renshaw | Buy |
모두보기
Gyre Therapeutics Inc 주식(GYRE)의 최신 뉴스
Gyre Therapeutics Inc. stock trend outlook and recovery pathTrend Reversal Probability Forecast Update - Newser
Regression analysis insights on Gyre Therapeutics Inc. performanceAlgorithmic Prediction of Market Breakouts - Newser
How to use a screener to detect Gyre Therapeutics Inc. breakoutsInsider Strategy for High Conviction Picks - Newser
Price momentum metrics for Gyre Therapeutics Inc. explainedFundamental + Technical Combined Watchlist - Newser
Gyre Therapeutics (GYRE) Projected to Post Earnings on Tuesday - Defense World
Using AI based signals to follow Gyre Therapeutics Inc.Free Reliable Chart-Based Trade Entries - Newser
Understanding Gyre Therapeutics Inc.’s price movementQuick Profit Setup with Signal Forecast - Newser
News impact scoring models applied to Gyre Therapeutics Inc.Asset Safety Selection Using Quantitative Analysis - Newser
Can you recover from losses in Gyre Therapeutics Inc.Automated AI Forecast with Trading Alerts - Newser
Candlestick signals on Gyre Therapeutics Inc. stock todayTrend Confirmation Scanner with Entry Focus - Newser
When is the best time to exit Gyre Therapeutics Inc.Free News Based Entry Opportunity Alerts - Newser
Bank of New York Mellon Corp Buys 2,596 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Why Gyre Therapeutics Inc. stock attracts strong analyst attentionTechnical Chart Summary for Momentum Stocks - Newser
Earnings visualization tools for Gyre Therapeutics Inc.Weekly Outlook for Short Term Investors - Newser
How hedge fund analytics apply to Gyre Therapeutics Inc. stockEntry Timing Tracker with Alert Accuracy - Newser
How institutional ownership impacts Gyre Therapeutics Inc. stockEquity Portfolio Outlook and Performance Summary - Newser
Gyre Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Daily Top Performing Stock Insights - Newser
Using flow based indicators on Gyre Therapeutics Inc.AI Generated Momentum Stock Forecast Guide - Newser
Gyre Therapeutics Inc. Breakout Confirmed by Volume MetricsStock Market Entry Timing Signals Revealed - metal.it
What makes Gyre Therapeutics Inc. stock price move sharplyBuild wealth with high-performing stocks - Jammu Links News
Should I hold or sell Gyre Therapeutics Inc. stock in 2025Get insider insights into market trends - Jammu Links News
What institutional investors are buying Gyre Therapeutics Inc. stockBreakthrough wealth creation - Jammu Links News
Is Gyre Therapeutics Inc. a good long term investmentMaximize your portfolio’s earning power - Jammu Links News
How volatile is Gyre Therapeutics Inc. stock compared to the marketExceptional profit velocity - Jammu Links News
Is Gyre Therapeutics Inc. stock overvalued or undervaluedUnmatched market gains - Jammu Links News
Why is Gyre Therapeutics Inc. stock attracting strong analyst attentionBuild wealth steadily with proven investment strategies - Jammu Links News
How does Gyre Therapeutics Inc. generate profit in a changing economyTremendous gains - Jammu Links News
What drives Gyre Therapeutics Inc. stock priceBoost your wealth with consistent growth stocks - Jammu Links News
What are Gyre Therapeutics Inc. company’s key revenue driversAchieve remarkable returns with smart investing - Jammu Links News
What are the technical indicators suggesting about Gyre Therapeutics Inc.Build a portfolio for long-term financial success - Jammu Links News
How strong is Gyre Therapeutics Inc. company’s balance sheetFree Investment Risk Control - Jammu Links News
What are the latest earnings results for Gyre Therapeutics Inc.Capitalize on emerging trends for profits - Jammu Links News
What catalysts could drive Gyre Therapeutics Inc. stock higher in 2025Explosive capital appreciation - Jammu Links News
What are analysts’ price targets for Gyre Therapeutics Inc. in the next 12 monthsExceptional risk-adjusted gains - Jammu Links News
Combining price and volume data for Gyre Therapeutics Inc.Trading Volume Spike and Reversal Analysis - Newser
Sentiment Tools Show Shift in Trader Mood on Gyre Therapeutics Inc.Multi-Bagger Potential Stock Forecast Tools Released - metal.it
Published on: 2025-08-01 05:14:58 - Newser
Gyre Therapeutics Inc (GYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):